Girard Partners’s Encompass Health EHC Stock Holding History

Girard Partners’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-629	Closed	-$38K	–	394
2018 Q3	$38K	Buy	+629	New	+$38.2K	0.01%	494

Other funds holding EHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Girard Partners's EHC Position: Q4 2018 in Review

Girard Partners sold out of Encompass Health (EHC) in Q4 2018, closing a stake of 629 shares — an estimated $38K sold.

Girard Partners first reported a position in EHC in Q3 2018 and held it in 1 quarter. The position peaked at $38K in Q3 2018. 447 funds tracked by Wall St. Rank hold EHC as of Q4 2018.

Girard Partners reported no remaining Encompass Health position as of Q4 2018 after selling out during the quarter.
Girard Partners sold 629 Encompass Health shares in Q4 2018, an estimated $38K.
Girard Partners first reported a position in Encompass Health in Q3 2018 and held it in 1 quarter.
Girard Partners's Encompass Health position peaked at $38K in Q3 2018.
447 funds tracked by Wall St. Rank held Encompass Health as of Q4 2018.

Based on Girard Partners's 13F filing for Q4 2018, filed 11 Feb 2019.